Annual report [Section 13 and 15(d), not S-K Item 405]

Note 10 - Share-based Compensation - Schedule of Allocated Expense (Details)

v3.25.3
Note 10 - Share-based Compensation - Schedule of Allocated Expense (Details) - USD ($)
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Share-based compensation expense $ 8,102,177 $ 13,644,405
FC2 Female Condom [Member] | Discontinued Operations, Disposed of by Sale [Member]    
Share-based compensation expense, discontinued operations (10,049) 1,404,335
Selling, General and Administrative Expenses [Member]    
Share-based compensation expense 6,146,717 9,379,533
Research and Development Expense [Member]    
Share-based compensation expense $ 1,965,509 $ 2,860,537